Lv3
390 积分 2022-02-28 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
10个月前
已完结
Process development of tangential flow filtration and sterile filtration for manufacturing of mRNA-lipid nanoparticles: A study on membrane performance and filtration modeling
10个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
11个月前
已完结
Translational Medicine
1年前
已完结
Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook
1年前
已完结
皖公网安备34019202002308
